Literature DB >> 17133561

Phenomenology of dreams in Parkinson's disease.

Leora L Borek1, Robert Kohn, Joseph H Friedman.   

Abstract

Rapid eye movement sleep behavior disorder (RBD) occurs in approximately one third of patients with Parkinson's disease (PD) and is associated with a loss of muscle atonia during REM sleep and aggressive dream content. We examined the dream characteristics of PD patients to determine whether dream content differed between patients with RBD and without RBD, men and women with RBD, and men and women with PD. One hundred-twenty patients with a diagnosis of idiopathic PD were consecutively recruited from a movement disorders clinic and were assessed for RBD using clinical diagnostic criteria of the International Classification of Sleep Disorders Revised (2001). Verbatim dream content was obtained from each patient and categorized into dream themes that were coded into nominal categories. Fisher's exact tests determined whether particular dreams were correlated with RBD versus non-RBD, men and women with RBD, and men and women with PD. RBD patients had a higher percentage of violent dreams compared to non-RBD patients. There were no significant sex differences in the dream content of RBD patients. Men with PD had more aggressive dreams compared to females with PD. Aggressive dream content was characteristic of RBD patients and sex differences exist in the dream content of the PD population. (c) 2006 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17133561     DOI: 10.1002/mds.21255

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  16 in total

1.  Sleep disturbances in untreated Parkinson's disease.

Authors:  Jitka Bušková; Jiří Klempíř; Veronika Majerová; Jana Picmausová; Karel Sonka; Robert Jech; Jan Roth; Evžen Růžička
Journal:  J Neurol       Date:  2011-06-03       Impact factor: 4.849

Review 2.  Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure.

Authors:  Marc R Bothe; Ingo Uttner; Markus Otto
Journal:  J Neural Transm (Vienna)       Date:  2010-01-30       Impact factor: 3.575

3.  Sleep disorders and daytime sleepiness in Parkinson's disease.

Authors:  Renee Monderer; Michael Thorpy
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

4.  Dream features in the early stages of Parkinson's disease.

Authors:  Paulo Bugalho; Teresa Paiva
Journal:  J Neural Transm (Vienna)       Date:  2011-06-30       Impact factor: 3.575

Review 5.  Idiopathic REM sleep behaviour disorder and neurodegeneration - an update.

Authors:  Birgit Högl; Ambra Stefani; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2017-11-24       Impact factor: 42.937

6.  Nocturnal moaning and groaning-catathrenia or nocturnal vocalizations.

Authors:  Adnan A Abbasi; Timothy I Morgenthaler; Nancy L Slocumb; Maja Tippmann-Peikert; Eric J Olson; Kannan Ramar
Journal:  Sleep Breath       Date:  2011-03-05       Impact factor: 2.816

7.  Clinical features associated with REM sleep behavior disorder symptoms in the early stages of Parkinson's disease.

Authors:  Paulo Bugalho; Joaquim Alves da Silva; Bernardo Neto
Journal:  J Neurol       Date:  2010-08-09       Impact factor: 4.849

8.  The REM Sleep Behavior Disorder Screening Questionnaire: Validation Study of the Korean Version (RBDQ-KR).

Authors:  Sooyeoun You; Hye-Jin Moon; So Young Do; Yun-Kwok Wing; Jun-Sang Sunwoo; Ki-Young Jung; Yong Won Cho
Journal:  J Clin Sleep Med       Date:  2017-12-15       Impact factor: 4.062

9.  REM sleep behavior disorder in Parkinson's disease: a questionnaire-based survey.

Authors:  Rositsa Poryazova; Michael Oberholzer; Christian R Baumann; Claudio L Bassetti
Journal:  J Clin Sleep Med       Date:  2013-01-15       Impact factor: 4.062

Review 10.  Rapid eye movement sleep behavior disorder.

Authors:  Michael C Chen; Huan Yu; Zhi-Li Huang; Jun Lu
Journal:  Curr Opin Neurobiol       Date:  2013-03-18       Impact factor: 6.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.